Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The spreading of pathology within and between brain areas is a hallmark of neurodegenerative disorders. In patients with Alzheimer’s disease, deposition of amyloid-β is accompanied by activation of the innate immune system and involves inflammasome-dependent formation of ASC specks in microglia. ASC specks released by microglia bind rapidly to amyloid-β and increase the formation of amyloid-β oligomers and aggregates, acting as an inflammation-driven cross-seed for amyloid-β pathology. Here we show that intrahippocampal injection of ASC specks resulted in spreading of amyloid-β pathology in transgenic double-mutant APPSwePSEN1dE9 mice. By contrast, homogenates from brains of APPSwePSEN1dE9 mice failed to induce seeding and spreading of amyloid-β pathology in ASC-deficient APPSwePSEN1dE9 mice. Moreover, co-application of an anti-ASC antibody blocked the increase in amyloid-β pathology in APPSwePSEN1dE9 mice. These findings support the concept that inflammasome activation is connected to seeding and spreading of amyloid-β pathology in patients with Alzheimer’s disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-1 beta was shown to exacerbate tau pathologies [97] and reduce microglial phagocytic activity [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“Rat research has identified the NLRP3-ASC inflammasome as a major mechanism through which microglia may drive pathological features of AD [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“In turn, the NLRP3 inflammasome is essential for the development and progression of Aβ pathology in mice29 and may drive tau pathology through Aβ-induced microglial activation30.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [29]
In the citing paper
“Pyroptosis of glial cells leads to release of ASC specks into the extracellular space, where it binds rapidly to Aβ peptides, increasing the aggregation of Aβ.357”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [357]
In the citing paper
“In that study, ASC-bound Aβ was detected in brain samples from AD patients, but not in samples from age-matched controls without dementia.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [80]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Self-citationScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Self-citationUnified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Lu, A., Magupalli, V. G., Ruan, J., Yin, Q., Atianand, M. K., Vos, M. R., Schröder, G. F., Fitzgerald, K. A., Wu, H., & Egelman, E. H. (2014) · Cell · doi:10.1016/j.cell.2014.02.008 · Cited by 1,353
Cited by
Items 601–700 of 1,002
Sharma, S., Risen, S. J., Gilberto, V. S., Boland, S. W., Chatterjee, A., Moreno, J. A., & Nagpal, P. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00024 · Cited by 13
Scholes, H. M., Cryar, A., Kerr, F., Sutherland, D., Gethings, L. A., Vissers, J. P. C., Lees, J., Orengo, C. A., Partridge, L., & Thalassinos, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-74748-9 · Cited by 13
Peptidyl arginine deiminase 4 and its potential role in Alzheimer's disease
Wang, L., Song, Y., Mi, J.-H., & Ding, M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110466 · Cited by 13
Direct oral anticoagulants: a new therapy against Alzheimer’s disease?
Grossmann, K. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303029 · Cited by 14
Literature Overview of the Relation Between Psoriasis and Alzheimer
Yang, Q., Wang, J., Mi, N., & Zou, Y. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s403854 · Cited by 13
Zhang, W., Wu, C.-C., Ge, M.-M., Yuan, X.-M., Han, S.-Y., Zhao, F.-T., Zhang, X., Gao, F., Tian, Y.-K., Zhang, G., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110119 · Cited by 14
Shao, N., Ding, Z., Liu, F., Zhang, X., Wang, X., Hu, S., Ye, S., Wang, T., Si, W., & Cai, B. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04547-0 · Cited by 13
“ASC, as an important component of inflammasomes, bound to A β , leading to A β aggregation and oligomerization, which promoted inflammation development [51].”
Neurodegeneration and the immune system: lessons from autoimmune encephalitis
Campetella, L., Smolik, K., Farina, A., Joubert, B., Muñiz‐Castrillo, S., Desestret, V., & Honnorat, J. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13094-0 · Cited by 13
Exploring the Role of NLRP3 in Neurodegeneration: Cutting‐Edge Therapeutic Strategies and Inhibitors
Mustafa, M. A., Bansal, P., Pallavi, M., Panigrahi, R., Nathiya, D., Kumar, S., Al-Hasnaawei, S., Chauhan, A. S., & Singla, S. (2025) · Developmental Neurobiology · doi:10.1002/dneu.22982 · Cited by 12
“Blocking ASC in mouse models—either genetically or using anti-ASC antibodies—has been shown to reduce the spread of amyloid pathology (Venegas et al. 2017).”
Self-citationBrezáni, V., Joshi, R., Ortega‐Ribera, M., Nagesh, P. T., Brezani, V., Zivny, A., Kurt‐Jones, E. A., Golenbock, D. T., & Szabó, G. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03501-8 · Cited by 13
“2H), supporting their role as major producers of ASC specks [97].”
Self-citationNew Approaches to the Treatment of Alzheimer’s Disease
Kruk-Słomka, M., Kuceł, D., Małysz, M., Machnikowska, A., Orzelska‐Górka, J., & Biała, G. (2025) · Pharmaceuticals · doi:10.3390/ph18081117 · Cited by 14
Wei, M., Li, W., Bao, G., Yang, Z., Li, S., & Le, W. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118918 · Cited by 12
Guo, X., Zhang, G., Peng, Q., Liu, H., Ye, K., Xiao, T., Liu, C., Zhang, X., Li, S., Wang, H., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106158 · Cited by 14
Volonté, C., Hu, G., Shaw, C. A., Claudio, V. J., dos Santos, J. A., Vaz, S. H., Sebastião, A. M., Balcar, V. J., Mozley, P. D., Verde, F., et al. (2026) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2026.1004136 · Cited by 14
Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
Rudman, M. D., Ulrich, J. D., & Holtzman, D. M. (2026) · Cell · doi:10.1016/j.cell.2026.06.006 · Cited by 19
Lee, S., Ryu, S. M., Kim, D., Lee, Y. E., Lee, S., Kang, S., Kim, J., & Lee, S.-I. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115451 · Cited by 12
Onaolapo, O. J., Olofinnade, A. T., Ojo, F. O., & Onaolapo, A. Y. (2021) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523021666220815151559 · Cited by 12
Reimers, D., Vallejo-Muñoz, M., Casarejos, M. J., Jiménez‐Escrig, A., Gonzalo‐Gobernado, R., & Bazán, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168697 · Cited by 14
“These results seem to be in contradiction with previous in vivo studies, where the authors immunohistochemically detect NLRP3 in microglia surrounding Aβ plaques in the HP of 16 month-old APPswePSEN1dE9 mice, using the same anti-NLRP3 antibody as us [1].”
BackgroundInfluentialParadoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse model
Verheijen, B. M., Stevens, J., Gentier, R. J. G., Hekke, C. D. V. ‘., van den Hove, D., Hermes, D. J. H. P., Steinbusch, H. W. M., Ruijter, J. M., Grimm, M. O. W., Haupenthal, V. J., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.011 · Cited by 14
How Microglia Manages Non-cell Autonomous Vicious Cycling of Aβ Toxicity in the Pathogenesis of AD
Seol, Y., Ki, S., Ryu, H. L., Chung, S., Lee, J.-H., & Ryu, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.593724 · Cited by 15
“Using purified ASC specks generated by immunoprecipitation and enzymatic cleavage, Aβ cross-seeding activity resulted in the acceleration of Aβ oligomerization and aggregation in injected APP/PS1 mice (Venegas et al., 2017; Friker et al., 2020) compared to ASC-deficient APP/PS1 mice.”
BackgroundInfluentialKumar, A., Doan, V. M., Kunkli, B., & Csősz, É. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.633050 · Cited by 14
Ahuja, G., Arauz, Y. L. A., van Heuvelen, M. J. G., Kortholt, A., Oroszi, T., & van der Zee, E. A. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1422152 · Cited by 12
“ASC facilitates inflammasome assembly, further promoting inflammation in neurodegenerative diseases (94).”
BackgroundAmyloid-β-activated microglia can induce compound proteinopathies
Lee, S. H., Bae, E.-J., Pérez-Acuña, D., Jung, M. K., Han, J. W., Mook‐Jung, I., & Lee, S. (2024) · Brain · doi:10.1093/brain/awae221 · Cited by 12
Regulated cell death in chronic kidney disease: current evidence and future clinical perspectives
Giuliani, K. T. K., Adams, B. C., Healy, H. G., & Kassianos, A. J. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1497460 · Cited by 11
Su, J., Zhao, L., Fu, R., & Tang, Z. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70329 · Cited by 12
Balancing Microglial Density and Activation in Central Nervous System Development and Disease
Wang, S., Pan, L., Sun, C., Ma, C., & Pan, H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47050344 · Cited by 12
“…by microglial NLRP3 activation TREM2 signaling is regarded to promote microglial proliferation, cytokine secretion, and phagocytosis, regulating microglial survival and metabolism [101–103]. facilitate tau release tau, creating a self-perpetuating degenerative cycle [68,112–117] Deletion of”
Böröczky, C., Paszternák, A., Laufer, R., Tarnóczi, K., Sikur, N., Bagaméry, F., Szökő, É., Varga, K., & Tábi, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146581 · Cited by 12
“Compared to more complex systems such as iPSC-derived neurons or cerebral organoids, which are often costly and require advanced infrastructure, this approach offers higher throughput and robustness without sacrificing key inflammatory features [8,44,45].”
Neuroimmune Dysregulation and AI-Driven Therapeutic Strategies in Alzheimer’s Disease
Ghosh, S., Bhaskar, R., Singh, K. K., Sharma, S., Yarlagadda, B., Sinha, J. K., & Han, S. S. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01651-0 · Cited by 11
“The NLRP3 inflammasome structurally consists of NLRP3 pro - tein, apoptosis-associated speck-like protein with a caspase recruitment domain (ASC), and pro-caspase-1 (Venegas et al. 2017; Kelley et al. 2019; Ye et al. 2023).”
Kim, Y., Ha, T.-Y., Kondaurova, O., Lee, M.-S., & Chang, K. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03728-z · Cited by 13
Johnson, A. M., Ou, Z.-Y. A., Gordon, R., & Saminathan, H. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106113 · Cited by 11
Bai, H., Zhang, Z., Ma, X., Shen, M., Li, R., Li, S., Qiu, D., & Gao, L. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113229 · Cited by 12
Xie, J.-Y., Wang, Z., Liu, W.-Y., Liu, H.-W., Li, D., Sang, Y.-F., Yang, Z. M., Gao, J., & Yan, X. (2023) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c00226 · Cited by 11
Spurlock, M. S., An, W., Reshetnikova, G., Wen, R., Wang, H., Braha, M., Solis, G., Kurtenbach, S., Galindez, O. J., Vaccari, J. P. D. R., et al. (2023) · Cells · doi:10.3390/cells12222626 · Cited by 11
Liu, B., Luo, W., Huang, L., Wei, C., Huang, X., Liu, J., Tao, R., Mo, Y., & Li, X. (2024) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175241238577 · Cited by 12
“27 The MIF-mediated alterations in macrophage activity might hamper their ability to ef fi ciently clear A β , 28 thereby contributing to plaque persistence and disease progression.”
BackgroundNeuroinflammation als Motor der Alzheimer-Erkrankung
Castro‐Gomez, S., Binder, J., & Heneka, M. T. (2019) · Der Nervenarzt · doi:10.1007/s00115-019-0778-3 · Cited by 17
Self-citationPlatelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease
Page, M. J., & Pretorius, E. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1733960 · Cited by 12
Supramolecular organizing centers at the interface of inflammation and neurodegeneration
Sušjan, P., Ramuta, T. Ž., Boršić, E., Orehek, S., & Hafner‐Bratkovič, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940969 · Cited by 13
“Furthermore, Venegas et al. (2017) demonstrated that ASC specks released by microglia bind Ab molecules enhance their aggregation and increase the formation of Ab aggregates acting as an inflammation-driven cross-seed for Ab pathology (218).”
BackgroundInfluentialChen, H. H., Chen, X., Sun, P., Wu, D., Hu, Y., Pan, J., Li, X., Zhang, C., Wu, X., Hua, L., et al. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128160 · Cited by 11
Li, J., Chen, M., Fu, T., Liu, F., Liu, J., Xu, C., Zhou, J., Rao, Y., Jiang, Z., & Huang, L. (2025) · Phytochemistry · doi:10.1016/j.phytochem.2025.114440 · Cited by 10
Yuasa‐Kawada, J., Kinoshita-Kawada, M., Hiramoto, M., Yamagishi, S., Mishima, T., Yasunaga, S., Tsuboi, Y., Hattori, N., & Wu, J. Y. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01330 · Cited by 11
“Extracellular ASC specks bind to Aβ, serving as the core for Aβ seeding/cross-seeding, thereby enhancing Aβ pathology (Heneka et al., 2013, 2018; Venegas et al., 2017; Swanson et al., 2019).”
Maphis, N. M., Hulse, J. P., Peabody, J., Dadras, S., Whelpley, M. J., Kandath, M., Wilson, C. M., Hobson, S., Thompson, J., Poolsup, S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70101 · Cited by 12
“33,34 Furthermore, we have reported previously that these alterations can be mitigated through pT181-Qß vaccination in the rTg4510 mouse model of tauopathy.”
Protein palmitoylation: an emerging regulator of inflammatory signaling and diseases
Chen, R., Tang, X., Wang, Y., Wang, B., & Mao, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1652741 · Cited by 17
“Alzheimer ’ s disease (AD) is one of the most common neurodegenerative disorders induced by chronic neuroin fl ammation withincreasedactivationofmicrogliaandastrocytes,leadingtocognitive impairment and dementia (213, 214).”
Madhi, I., Kim, J.-H., Shin, H. S., So, Y. H., Jung, E., & Kim, Y. (2025) · Journal of Ginseng Research · doi:10.1016/j.jgr.2025.10.008 · Cited by 10
“Similarly, neutralizing ASC specks or disrupting the NLRP3 – ASC axis decreased A β pathology and improved memory performance [33].”
Alzheimer's disease: from molecular pathways to therapies
Feng, J.-Q., Yang, L.-L., Ya-xi, L., & Yao, X. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00443-2 · Cited by 11
“…expansion of activated microglia leads to increased release of proinflammatory cytokines, which further promotes Aβ plaque formation and establishes a self-amplifying cycle that exerts direct neurotoxic effects-a phase often described as the destructive stage of microglial activation [115, 116].”
“Other Than NLRP3” Inflammasomes: Multiple Roles in Brain Disease
Chiarini, A., Armato, U., Gui, L., & Prà, I. D. (2022) · The Neuroscientist · doi:10.1177/10738584221106114 · Cited by 11
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01649-z · Cited by 11
“Likewise, microglia, cells of mesodermal/mesenchymal origin, are important in the formation of senile plaques [71].”
BackgroundZheng, C., Zhao, W. D., Yang, Z., Guo, S., & Initiative, A. D. N. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25280 · Cited by 10
“Immune cells (e.g., microglia) play a potential role in regulating the development, structure, and function of brain networks (Garaschuk & Verkhratsky, 2019 ), and its activation plays a two-way role in the pathogenesis of AD (Venegas et al., 2017 ; Zhao et al., 2018 ).”
BackgroundSharma, S., Gilberto, V. S., Rask, J. C., Chatterjee, A., & Nagpal, P. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00160 · Cited by 11
Microglia‐derived Galectin‐9 drives amyloid‐β pathology in Alzheimer's disease
Zhang, G., Peng, Q., Guo, X., Pan, L., Xiong, M., Zhang, X., Dai, L., Zhang, Z., Xiao, T., He, J., et al. (2024) · Aging Cell · doi:10.1111/acel.14396 · Cited by 13
“Mouse brain homogenates (cortex and hippocampus) were prepared from WT, Gal-9 KO, APP/PS1, and APP/PS1;Gal-9 KO mice (12 months old) following the previously described method (Venegas et al., 2017 ).”
Tissue-specific features of microglial innate immune responses
Timmerman, R., Burm, S. M., & Bajramovic, J. J. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104924 · Cited by 13
Tomizawa, I., Nakagawa, H., Sohma, Y., Kanai, M., Hori, Y., & Tomita, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.945017 · Cited by 11
Yi, X., de Souza, B. M., Sawatani, T., Szymczak, F., Marselli, L., Marchetti, P., Cnop, M., & Eizirik, D. L. (2022) · iScience · doi:10.1016/j.isci.2022.105376 · Cited by 11
Roles of Microglia in AD Pathology
Gao, R., Wu, H., Li, Q., & Zhao, J. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230203112351 · Cited by 10
The indispensability of macrophage adaptor proteins in chronic inflammatory diseases
Atre, R., Sharma, R., Gaponenko, V., Solanki, K., Wadhonkar, K., Singh, N., Patidar, P., Khabiya, R., Samaur, H., Banerjee, S., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110176 · Cited by 10
Tijms, B. M., Vromen, E. M., Mjaavatten, O., Holstege, H., Reus, L. M., van der Lee, S., Wesenhagen, K. E., Lorenzini, L., Vermunt, L., Venkatraghavan, V., et al. (2023) · doi:10.1101/2023.05.10.23289793 · Cited by 10
Ren, H., Tang, L. Y., Yuan, Z., Liu, Y., Zhou, X., Xiao, X., Wu, X., Chen, W., Chen, Y., Wang, H., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1492237 · Cited by 9
Inflammasomes in Alzheimer’s Progression: Nrf2 as a Preventive Target
López-Hernández, R., de la Torre-Álamo, M. M., García-Bueno, B., Baroja‐Mazo, A., Fenoy, F. J., & Cuevas, S. (2025) · Antioxidants · doi:10.3390/antiox14020121 · Cited by 12
Mo, M., Eriksdotter, M., Ajeganova, S., Mitra, S., Ptacek, S. G., & Xu, H. (2025) · Neurology · doi:10.1212/wnl.0000000000213405 · Cited by 11
Neuropathological links between T2DM and LOAD: systematic review and meta-analysis
Lemche, E., Hortobágyi, T., Kiecker, C. M., & Turkheimer, F. (2025) · Physiological Reviews · doi:10.1152/physrev.00040.2024 · Cited by 11
Huang, Z., Wang, Y., Lin, F., Luo, Z., Xu, H., Alifu, N., Li, J., Weng, X., Sun, Y., Song, J., et al. (2025) · Matter · doi:10.1016/j.matt.2025.102102 · Cited by 9
Wu, W., Meng, T., Han, L., Jin, F., Han, P., & Zhou, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1630205 · Cited by 14
“…bacterial amyloids can activate the NLRP3 in fl ammasome through Toll-like receptor 2 (TLR2), leading to the release of downstream pro-in fl ammatory factors by microglia, which ultimately contribute to A β and tau aggregation (Ising et al., 2019; Tejera et al., 2019; Venegas et al., 2017).”
Glial Cells in Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Frontiers
Sil, M., Mukherjee, N., Chatterjee, I., Ghosh, A., & Goswami, A. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02379-8 · Cited by 10
“Although NG2 cell counts may be maintained or even expanded in initial stages (Sekar 2015), AD human white matter postmortem usually demonstrates compromised NG2 cell density and defective maturation into myelinating oligodendrocytes (Venegas 2017).”
Zhang, J., Xie, D., Jiao, D., Zhou, S. Y., Liu, S., Ju, Z., Hu, L., Li, Q., Yao, C., & Chen, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32688 · Cited by 19
“Consequently, this leads to pyroptosis and the release of significant amounts of ASC, cycling the formation of ASC-A β complexes [80].”
BackgroundTargeting NLRP3 Inflammasomes: A Trojan Horse Strategy for Intervention in Neurological Disorders
Tork, M. A. B., Fotouhi, S., Roozi, P., & Negah, S. S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04359-2 · Cited by 11
“Studies have definitively demonstrated that Aβ aggregates trigger the activation of the NLRP3-ASC inflammasome [48], and conversely, the stimulation of the NLRP3-ASC inflammasome worsens amyloid pathology in vivo [49], including via prion-like ASC speck cross-seeding [50].”
Almalki, W. H., & Almujri, S. S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155614 · Cited by 9
Zheng, R., Zhang, J., Han, X., Wu, Y., Yan, J., Song, P., Wang, Y., Wu, X., & Zhang, H. (2021) · Environmental Science Nano · doi:10.1039/d1en00361e · Cited by 11
Zhang, P.-F., Wang, Z.-T., Liu, Y., Hu, H., Sun, Y., Hu, H.-Y., Ma, Y.-H., Tan, L., & Yu, J.-T. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220057 · Cited by 10
“Importantly, neuroin-flammation triggered by immune cell responses in the brain is upstream or parallel to AD pathological proteins [3].”
Lu, M., Hao, C., Xu, L., Feng, Y., Jiang, J., Wang, Y., Xu, J., Kuang, H., Xu, C., & Sun, M. (2024) · Science China Chemistry · doi:10.1007/s11426-023-1859-4 · Cited by 9
Nanoparticle-based delivery of polyphenols for the treatment of inflammation-associated diseases
Fuior, E.-V., & Călin, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819666-3.00012-2 · Cited by 10
Anti-neuroinflammatory effects in vitro and in vivo, and chemical profile of Jatropha curcas L
Wang, Y., Zhou, D., Meng, Q., Xu, L., Yao, X., Ni, X., Xie, H., Wu, G., Chen, G., Hou, Y., et al. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105720 · Cited by 9
Bartfai, T., & Lees, G. V. (2020) · ASN NEURO · doi:10.1177/1759091420918557 · Cited by 9
Španić, E., Vogrinc, D., Fuller, H. R., Horvat, L. L., Mayer, D., Kopić, J., Pintarić, K., Leko, M. B., Pravica, M., Krsnik, Ž., et al. (2024) · Biomolecules · doi:10.3390/biom14030302 · Cited by 8
“…polymorphisms [115] and the prior activation of the NLRP3 inflammasome in microglia, e.g., by extracellular amyloid [82] or templated tau seeds [116], are also suggested, with conceivable spreading by ASC proteins (“specks”) and possibly intracellular amyloid or other intracellularly generated…”
BackgroundChe, P., Cai, L., Liu, F., Wang, Y., Zhang, Y., Wang, Y., Lu, Q., Piao, Z., Zhang, X., Qin, W., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03402-7 · Cited by 9
“…can be measured via cerebrospinal fl uid (CSF) or plasma levels of neuro fi lament light chain, magnetic resonance imaging (MRI) or 18 F-fl uorodeoxyglucose (FDG)-PET, and neuroin fl ammation [4] and cerebrovascular dysfunction [5], all of which have been suggested to be additional biomarkers for AD.”
Sterile innate immune mechanisms in neurodegenerative diseases
Ealy, A., Serapiglia, A. M., & Panicker, N. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111039 · Cited by 8
“Inflammasome-activated microglia were found to upregulate and secrete the adaptor protein ASC, which associated with extracellular A β , cross-seeding, and hastening its aggregation (38).”
Gallo, C., Verrillo, L., Manzo, E., Cauzzi, E., Barbera, L. L., Sabatino, G., Paolis, M. L. D., Sciacca, M. F. M., Barra, G., Peroni, E., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03634-w · Cited by 10
“This selective enhancement of oligomeric Aβ uptake is particularly noteworthy given recent discoveries linking these diffusible species to synaptic loss, oxidative stress, and tau pathology [72, 73].”
Tang, K., Wan, M., Zhang, H., Zhang, Q., Yang, Q., Chen, K., Wang, N., Zhang, D., Qiu, W., & Ma, C. (2020) · Cell and Tissue Banking · doi:10.1007/s10561-020-09849-w · Cited by 8
Wu, Z., Yang, Y., Song, Z., Ma, M., Feng, M., Liu, Y., Xing, H., Chang, Y., & Dai, H. (2022) · Brain Sciences · doi:10.3390/brainsci12121681 · Cited by 9
Wang, Y., Gong, Q., Pan, H., Wang, X., & Yan, C. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148687 · Cited by 8
Light on Alzheimer’s disease: from basic insights to preclinical studies
Mi, J., Liu, C., Chen, H., Qian, Y., Zhu, J., Zhang, Y., Liang, Y., Wang, L., & Ta, D. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1363458 · Cited by 8
Kadam, R., Gupta, M., Lazarov, O., & Prabhakar, B. S. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae134 · Cited by 9
Mechanism of NLRP3 inflammasome activation and its role in Alzheimer’s disease
Gao, X., Zhang, X., Sun, Y., & Dai, X. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00048 · Cited by 12
Savonenko, A. V., Wong, P. C., & Li, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00022-8 · Cited by 9
Amyloids and brain cancer: molecular linkages and crossovers
Singh, S., Joshi, V., & Upadhyay, A. (2023) · Bioscience Reports · doi:10.1042/bsr20230489 · Cited by 8
“A recent study by Heneka group showed a phenomenon called ‘a perfect storm’ caused by amyloid cross-seeding mediated by microglial origin ASC (apoptosis-associated speck-like protein containing A CARD) specks [164].”
BackgroundWang, Y., Chen, G., Zhou, D., Xu, L., Meng, Q., Lin, B., Hao, J., Sun, F., Hou, Y., & Li, N. (2024) · Phytochemistry · doi:10.1016/j.phytochem.2024.114008 · Cited by 8
Wang, T., Han, L., Zhang, X., Wu, R., Cheng, X., Zhou, W., & Zhang, Y. (2018) · Molecules · doi:10.3390/molecules23061312 · Cited by 8
High Mobility Group Box 1 Ameliorates Cognitive Impairment in the 3×Tg-AD Mouse Model
Zhang, J. C., Hua, X., Gu, J., Chen, F., Gu, J., Gong, C., Liu, F., & Dai, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191110 · Cited by 8
Transcriptomics of autoimmune diseases identifies FGFR1 as a target for pancreatic β-cell protection
Yi, X., Zimath, P. L., Martín-Vázquez, E., Oliveira, J. G., Jawurek, S., Title, A. C., Yesildag, B., Mourad, N. I., Buemi, A., Pattou, F. N., et al. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103469 · Cited by 7
Kumar, R., Panda, S. P., Abomughaid, M. M., Lakhanpal, S., Avinash, D., Jha, N. K., & Gupta, R. V. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01685-9 · Cited by 7
“Pyroptotic microglia release apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), which binds to Aβ and promotes its aggregation, resulting in the formation of ASC-Aβ complexes that will enhance neuroinflammatory cascades (Venegas et al. 2017 ; Friker et al. 2020).”
Long, I. (2025) · Biomedical Research and Therapy · doi:10.15419/s00m4g68 · Cited by 7
Neuronal inflammasomes: balancing immunity, neuroinflammation, and homeostasis
Vaccari, J. P. D. R., & Keane, R. W. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.11.007 · Cited by 10
Singh, A. S., Naqvi, A. R., & Chanu, M. T. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.01.050 · Cited by 7
Umino, M., Okuda, M., Ohkubo, T., Fujii, T., & Matsubara, K. (2023) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbad135 · Cited by 7
Vontell, R., Gober, R., Dallmeier, J., Brzostowicki, D. J., Barreda, A., Blennow, K., Zetterberg, H., Kvartsberg, H., Gultekin, S. H., Vaccari, J. P. D. R., et al. (2024) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12444 · Cited by 12
“36–38 Hence it seems possible that as AD pathology progresses from CA1 to the other hippocampal subfields ASC would oligomerize in the microglia.”
BackgroundBerezutsky, М. А., Дурнова, Н. А., & Andronova, T. A. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202412404122 · Cited by 7
Grenon, M. B., Papavergi, M.-T., Bathini, P., Sadowski, M. J., & Lemere, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115754 · Cited by 7
“…them to migrate and initiate immune responses, leading to the secretion of chemokines and pro-inflammatory cytokines [145], while it may also entail the inflammasome-dependent formation of ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain) specks in microglia [146].”
BackgroundImam, A., Oyegbola, C. B., Busari, M. O., Gbemisola, A. M., Abubakar, L., Odunayo, A. T., Attai, A. G., Iyiola, A. M., Imam, W. A., Akorede, A. A., et al. (2025) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-00860-z · Cited by 8
Toscano, E. C. D. B., Justo, A. F. O., de Paula, M. C. A., Grossi, L. B., Neves, V. H., Leite, R. E. P., Paes, V. R., Melo, R. C. N., Nitríni, R., Pasqualucci, C. A., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04975-6 · Cited by 8
“The released ASC protein can bind to Aβ, increasing aggregate formation and spreading amyloid pathology [19, 20].”
InfluentialChen, Y., Li, M., Zheng, Y., & Li, Y. (2019) · Journal of Visualized Experiments · doi:10.3791/59310 · Cited by 8
Sánchez, K. E., Bhaskar, K., & Rosenberg, G. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.976108 · Cited by 7
“The ASC and pro-caspase 1 components of the complex lead to caspase 1 activation that results in the processing of cytoplasmic targets, including IL-1β and IL-18 (Sutterwala et al., 2006; Franklin et al., 2014; Facci et al., 2018; Ribeiro et al., 2020; Scott et al., 2020).”
BackgroundInfluentialPlaque attack: Microglia have hard feelings toward amyloid-β
Davis, H., & Attwell, D. (2023) · Neuron · doi:10.1016/j.neuron.2022.11.014 · Cited by 7
Metadata
- Authors
- Venegas, C., Kumar, S., Franklin, B. S., Dierkes, T., Brinkschulte, R., Tejera, D., Vieira-Saecker, A., Schwartz, S., Santarelli, F., Kummer, M. P., Griep, A., Gelpi, E., Beilharz, M., Riedel, D., Golenbock, D. T., Geyer, M., Walter, J., Latz, E., & Heneka, M. T.
- Affiliations
- University of Bonn (DE)
- Max Planck Institute for Biophysical Chemistry (DE)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Heneka, Michael T.
- ORCID
- Venue
- Nature
- Published
- 2017-12
- Volume
- 552
- Issue
- 7685
- Pages
- 355-361
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777928756
- Semantic Scholar
- cb17ef0ab08a09442fa73b451fad4635f8d4ab3b
- Cited by
- 983
- References
- 33
- Citations by year
- 2026: 90 · 2025: 112 · 2024: 135 · 2023: 129 · 2022: 130 · 2021: 129 · 2020: 108 · 2019: 81 · 2018: 64 · 2017: 1
- FWCI
- 51.62
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, amyloid-beta, ASC specks, microglia, inflammasome, cross-seeding, amyloid-beta oligomers, innate immunity, neuroinflammation, amyloid-beta aggregation
- MeSH terms
- Protein Domains, Alzheimer Disease, Animals, Antibodies, Female, Hippocampus, Humans, Inflammation, Mice, Inbred C57BL, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Microglia, Mice, Knockout, Mice, CARD Signaling Adaptor Proteins, Presenilin-1, Inflammasomes, Spatial Memory, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.